Validation of computed tomographic lung densitometry for monitoring emphysema in α1-antitrypsin deficiency

Thorax

Volumn 61, Issue 6, 2006, Pages 485-490

  Parr, D G ^a   Stoel, B C ^b   Stolk, J ^b   Stockley, R A ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DENSITOMETRY; DISEASE COURSE; EMPHYSEMA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ADULT; ALPHA 1-ANTITRYPSIN DEFICIENCY; DENSITOMETRY, X-RAY; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PULMONARY EMPHYSEMA; SENSITIVITY AND SPECIFICITY; SMOKING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33745135090     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2005.054890     Document Type: Article

References (35)

1. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977;1:1645-8.
2. Kerstjens HA, Brand PL, Postma DS. Risk factors for accelerated decline among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;154:5266-72.
3. 1-antitrypsin deficiency (PiZZ). Eur Respir J 1999;13:247-51.
4. Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med 1968;278:1355-60.
5. Linhartovà A, Anderson AE Jr, Foraker AG. Topology of non-respiratory bronchioles of normal and emphysematous lungs. Hum Pathol 1974;5:729-35.
6. Ciba Guest Symposium Report. Terminology, definitions, and classification of chronic pulmonary emphysema and related conditions. A report of the conclusions of a CIBA guest symposium. Thorax 1959;14:286-99.
7. Snider G, Kleinerman J, Thurlbeck W, et al. The definition of emphysema: Report of a National Heart, Lung, and Blood Institute, Division of Lung Disease Workshop. Am Rev Respir Dis 1985;132:182-5.
8. Gould GA, MacNee W, McLean A, et al. CT measurements of lung density in life can quantitate distal airspace enlargement: an essential defining feature of human emphysema. Am Rev Respir Dis 1988;137:380-2.
9. Hayhurst MD, MacNee W, Flenley DC, et al. Diagnosis of pulmonary emphysema by computed tomography. Lancet 1984;2:320-2.
10. Hoffman EA, McLennan G. Assessment of the pulmonary structure-function relationship and clinical outcomes measures: quantitative volumetric CT of the lung. Acad Radiol 1997;4:758-66.
11. Mishima M, Hirai T, Itoh H, et al. Complexity of terminal airspace geometry assessed by lung computed tomography in normal subjects and patients with chronic obstructive pulmonary disease. Proc Natl Acad Sci USA 1999;96:8829-34.
12. Müller NL, Staples CA, Miller RR, et al. "Density mask". An objective method to quantitate emphysema using computed tomography. Chest 1988;94:782-7.
13. Uppaluri R, Hoffman EA, Sonka M, et al. Interstitial lung disease: a quantitative study using the adaptive features model. Am J Respir Crit Care Med 1999;159:519-25.
14. 1-antitrypsin deficiency as assessed by annual CT. Acta Radiol 1997;38:826-32.
15. 1-antitrypsin augmentation therapy. Am J Respir Crit Care Med 1999;160:1468-72.
16. 1-antitrypsin deficiency and factors associated with decline. Am J Respir Crit Care Med 2001;164:1805-9.
17. 1-antitrypsin deficiency. Thorax 2003;58:1027-30.
18. Parr DG, Stoel BC, Stolk J, et al. Influence of calibration on densitometric studies of emphysema progression using computed tomography. Am J Respir Crit Care Med 2004;170:883-90.
19. Gevenois PA, de Maertelaer V, De Vuyst P, et al. Comparison of computed density and macroscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1995;152:653-7.
20. Gevenois PA, De Vuyst P, de Maertelaer V, et al. Comparison of computed density and microscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1996;154:187-92.
21. Newell JD, Hogg JC, Snider GL. Report of a workshop: quantitative computed tomography scanning in longitudinal studies of emphysema. Eur Respir J 2004;23:769-75.
22. 1-antitrypsin deficiency. Thorax 2004;59:986-91.
23. Burrows B, Earle R. Course and prognosis of chronic obstructive lung dsease. N Engl J Med 1909;280:397-403.
24. Beaty TH, Menkes HA, Cohen BH, et al. Risk factors associated with longitudinal change in pulmonary function. Am Rev Respir Dis 1984;129:660-7.
25. Bosse R, Sparrow D, Rose CL. Longitudinal effects of age and smoking cessation on pulmonary function. Am Rev Respir Dis 1981;123:378-81.
26. Camill AE, Burrows B, Knudson RJ. Longitudinal changes in forced expiratory volume in one second in adults: effects of smoking and smoking cessation. Am Rev Respir Dis 1987;135:794-9.
27. Tager IB, Segal MR, Spelzer FE, et al. The natural history of forced expiratory volumes. Am Rev Respir Dis 1988;138:837-49.
28. 1-antitrypsin deficiency. Am J Respir Crit Care Med 2001; 163:936-41.
29. British Thoracic Society. Guidelines for the measurement of respiratory function. Recommendations of the British Thoracic Society and the Association of Respiratory Technicians and Physiologists. Respir Med 1994;88:165-94.
30. Fabbri LM, Hurd SS. Global strategy for the diagnosis, management and prevention of COPD: 2003 update. Eur Respir J 2003;22:1-2.
31. Buist AS, Burrows B, Eriksson S, et al. The natural history of air-flow obstruction in PiZ emphysema. Report of an NHLBI workshop. Am Rev Respir Dis 1983;127:543-5.
32. Thurlbeck WM. Measurement of pulmonary emphysema. Am Rev Respir Dis 1967;95:752-64.
33. 1-antitrypsin deficiency-associated emphysema. Invest Radiol 2001;36:648-51.
34. 1-antitrypsin deficiency influences lung function impairment. Am J Respir Crit Care Med 2004;170:1172-8.
35. 1-antitrypsin deficiency. Thorax 2003;58:1020-6.